Publications

5808 Results

Statin use, site of recurrence, and survival among post-menopausal women taking bisphosphonates as adjuvant therapy for primary breast cancer (SWOG S0307)

Authors
D Kizub;J Miao;A Stopeck;P Thompson;A Paterson;M Clemons;E Dees;J Ingle;CI Falkson;W Barlow;G Hortobagyi;JR Gralow
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster, P1-17-03
Year
2018
Research Committee(s)
Breast
Study Number(s)
S0307

Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel

Authors
P Lara;E Mayerson;C Tangen;A Goldkorn;Marta Van Loan;M Hussain;S Gupta;J Zhang;P Twardowski;DI Quinn;N Vogelzang;IM Thompson;N Agarwal
Journal / Conference
Annals of Oncology, Vol 29, Issue suppl_8, 1; ESMO 2018 Congress (October 19-23, Munich, Germany), poster
Year
2018
Research Committee(s)
Genitourinary
Study Number(s)
S1216

2nd Cycle Remission Achievement with 7+3 is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials

Authors
M Othus;E Estey;G Garcia-Manero;B Wood;DL Stirewalt;J Godwin;J Weick;J Anderson;F Appelbaum;H Erba;R Walter
Journal / Conference
Blood 132:3978; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333

Long-term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-adapted Approach

Authors
D Stephens;H Li;H Schoder;D Straus;C Moskowitz;M Leblanc;L Rimsza;N Bartlett;A Evens;A Lacasce;P Barr;M Knopp;E Hsi;J Leonard;B Kahl;S Smith;JW Friedberg
Journal / Conference
Blood 132:929; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Potential impact of consolidation radiation therapy for advanced Hodgkin Lymphoma: a secondary modeling of SWOG S0816 with receiver operating characteristic analysis

Authors
C Ha;H Li;H Schoder;C Pinnix;E Brem;N Bartlett;A Evens;E Hsi;L Rimsza;J Leonard;BS Kahl;M Leblanc;S Smith;L Constine;JW Friedberg
Journal / Conference
Blood 132:2927; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Lymphoma
Study Number(s)
S0816

A phase II study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell transplantation for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: CALGB Study 10701 (Alliance)

Authors
M Wieduwilt;J Yin;M Wetzler;G Uy;B Powell;J Kolitz;M Liedtke;W Stock;JH Beumer;R Mattsion;A Halvorson;S Devine;RM Stone;RA Larson
Journal / Conference
Blood 132:309; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10701

Event-free Survival as a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-level Analysis of Multiple Randomized Trials (Alliance A151614)

Authors
J Yin;B Laplant;E Storrick;J Uy;G Marcucci;H Fernandez;X Sun;S Petersdorf;F Appelbaum;M Othus;RA Larson;S Stone
Journal / Conference
Blood 132:1386; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), accepted, poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S0106

Predicting Non-Fatal Toxicities with 7+3 Induction Chemotherapy in Adult Acute Myeloid Leukemia: Analysis of SWOG Trial S1203

Authors
M Othus;G Garcia-Manero;F Appelbaum;HP Erba;R Walter
Journal / Conference
Blood 132:1403; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S1203

Bortezomib, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777 with Long-Term Follow Up

Authors
BGM Durie;A Hoering;R Sexton;M Abidi;J Epstein;SV Rajkumar;A Dispenzieri;S Kahanic;M Thakuri;F Reu;CR Reynolds;RZ Orlowski;B Barlogie
Journal / Conference
Blood 132:1992; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Myeloma
Study Number(s)
S0777

Prospective Study of Minimal Residual Disease (MRD) Status and Outcome After Complete Remission (CR) Following Intensive Remission Induction Therapy in Older Adults with Acute Myeloid Leukemia (AML): Analysis of the North American Intergroup E2906 Phase III Trial in Patients Age > 60 Years

Authors
J Foran;E Paietta;X Sun;J Racevskis;D Claxton;H Lazurus;M Thomas;A Melnick;R Levine;D Arber;Y Zhang;J Rowe;JE Godwin;J Altman;A Al-Kali;H Zheng;K Pratz;ER Broun;B Powell;K O'Dwyer;M Tallman;S Luger;M Litzow
Journal / Conference
Blood 132:437; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), accepted, oral/plenary
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E2906